Leerink Swann & Company (healthcare investment bank)
By AListNete
Keywords: Finance | US -- Boston/New England | Investment Banking

Short description for overview page

Full-service investment bank focused on high net worth clients in the healthcare industry


Tags

Investment bank, venture capital, private equity, life sciences, healthcare, biotechnology, JP Morgan, Lehman Brothers, Dartmouth, Harvard Business School, Harvard Medical School, Columbia Business School, and Yale Law School.


URL

http://www.leerink.com


Description

Leerink Swann & Company is a full-service investment banking firm that offers institutional sales, healthcare equity research, institutional trading, corporate finance, and asset management services for high net worth clients. The company facilitated the creation of MEDACorp, and integrated the healthcare consulting firm into its own investment banking services. MEDACorp provides access to more than 25,000 biomedical professionals and practicing physicians, resulting in widely respected expertise in the life sciences, regulatory affairs, reimbursement, and clinical trial design. It specializes in research on biotechnology, pharmaceuticals and diagnostic products.

The investment bank's clients range from pre-IPO to mid-cap life science companies. These include Helicos (IPO), Biodel (IPO), Orexigen (IPO), Inverness Medical Innovations, MannKind, and Northstar Neuroscience.


Alumni connected with this company

JP Morgan, Lehman Brothers, Dartmouth, Harvard Business School, Harvard Medical School, Columbia Business School, and Yale Law School.


City or Greater Metropolitan Area, State (and Country if not U.S.)
Boston, Massachusetts

Year founded
1995
» login or register to post comments

This profile uses publicly available information combined with AListNet info. This profile is provided to help alumni of McKinsey, Harvard, Stanford, Wharton, and other top institutions to network with each other. Top-tier alumni at this company person may or may not be a member of AListNet.